<DOC>
	<DOC>NCT01923948</DOC>
	<brief_summary>Pregabalin 150mg or placebo are administered 1 hour preoperatively in patients undergoing partial hepatectomy. Postoperatively, patients receive morphine as rescue analgesic. Morphine consumption in the first 48 hours is documented. Postoperative pain is measured by the visual analogue scale (VAS) score.</brief_summary>
	<brief_title>Preoperative Pain Control in Liver Surgery Patients</brief_title>
	<detailed_description>Methods: In this Randomized Controlled Trial, patients undergoing partial hepatectomy will be administered a single pre-operative dose of Pregabalin or a placebo. Primary endpoints are as follows: - Post-operative analgesic requirements - Post-operative VAS scale (rated 0-10) - Complications - Post-operative antiemetic requirement - Length of stay</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma, Hepatocellular</mesh_term>
	<mesh_term>Pain, Postoperative</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>patients undergoing partial hepatectomy contraindication against pregabalin creatinine &gt; 2.0 mg/dl GGT &gt;165, AST &gt;105, ALT &gt;135 peptic Ulcus haemorrhagic diathesis angina pectoris, myocardial infarction stroke bronchial asthma opioid abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Hepatocellular carcinoma</keyword>
	<keyword>Hepatectomy</keyword>
	<keyword>randomized controlled trials(RCTs)</keyword>
	<keyword>Postoperative Pain</keyword>
</DOC>